Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Notes Payables (2024 - 2025)

Mangoceuticals (MGRX) has disclosed Notes Payables for 2 consecutive years, with $100000.0 as the latest value for Q3 2025.

  • Quarterly Notes Payables changed N/A to $100000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $150000.0 for FY2024, N/A changed from the prior year.
  • Notes Payables hit $100000.0 in Q3 2025 for Mangoceuticals, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $150000.0 in Q4 2024 to a low of $87500.0 in Q1 2024.